Dr Jeff Mitchell
Honorary (Fellow)
Department of Medical Biology (WEHI)
6 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Divergent resistance pathways amongst SARS-CoV-2 PLpro inhibitors highlight the need for scaffold diversity
DOI: 10.1371/journal.ppat.10134682025
Journal article
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID
DOI: 10.1038/s41467-025-57905-42024
Journal article
Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape
DOI: 10.1038/s41467-024-50566-92022
Journal article
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors
DOI: 10.3389/fchem.2022.8612092020
Journal article
Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2
DOI: 10.15252/embj.20201062752018
Journal article
Sofosbuvir and daclatasvir therapy in patients with hepatitis C-related advanced decompensated liver disease (MELD ≥ 15)
DOI: 10.1111/apt.14404